Delivery Order SPE2DR25D2100-SPE2DR26FA0CY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $23,618.84 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location....
- The Defense Logistics Agency awarded a $27,401.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be fulfilled from the...
- The Defense Logistics Agency (DLA) awarded a $20,206.26 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in treating autoimmune conditions. This competitive award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. The contract involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under...
- The Defense Logistics Agency awarded a $37,093.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orencia ClickJect 125 mg/ml. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), requires performance completion by October 23, 2025. This delivery order was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support...
- The Defense Logistics Agency awarded a $76,256.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued on a...
- The Defense Logistics Agency awarded a $31,263.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, which is a child order under a larger indefinite delivery contract vehicle, was competitively awarded without set-aside designation on May 7, 2025, with an ultimate completion date of May 8, 2025. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $7,561.38 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product. The contract, designated as a firm fixed price delivery order with no set-aside, was awarded on May 6, 2025, with an ultimate completion date of May 7, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product for the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $13,069.86 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0CYDelivery Order
The Defense Logistics Agency awarded a $17,353.57 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. The contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for defense and civilian government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 11/17/25 |